PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
This is part 2 of a continuing education series produced in partnership with the SIDP Education Center (SIDPEC) on gram-negative bacterial resistance. It features expert speakers, Drs. Keith Kaye (@Keith_S_Kaye) and Kimberly Claeys (@ClaeysKcclaeys) and host Julie Ann Justo (@julie_justo). If you missed part 1 of this series, delivered as a webinar lecture, please go to sidp.org/SIDPEC to view that portion of the series first. In this podcast, our experts answer a collation of > 150 questions from interested viewers on the nuances of gram-negative bacterial resistance, from real-world formulary considerations to microbiology lab implementation and more.
Kim Claeys PharmD, PhD
Kim Claeys is an Assistant Professor in the Department of Practice, Sciences, and Health Outcomes Research at the University of Maryland School of Pharmacy and an antimicrobial stewardship pharmacist at the University of Maryland Medical Center. Dr. Claeys completed her PGY1 pharmacy practice residency at the University of Illinois at Chicago. Following this, she then completed her Infectious Diseases Health Outcomes Fellowship at Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences. Her research focuses on antimicrobial and diagnostic stewardship interventions to optimize treatment of bacterial infections, in particular those caused by gram negative organisms.
Keith Kaye, MD, MPH
Keith Kaye is a Professor of Medicine and Director of Research in the division of Infectious Diseases at the University of Michigan Medical School. He received his medical degree from the University of Pennsylvania and completed his Internal Medicine residency and Infectious Diseases fellowship at Beth Israel Deaconess Medical Center in Boston, MA. During fellowship, Dr. Kaye earned a Masters in Public Health from the Harvard School of Public Health. Dr. Kaye has authored over 250 peer-reviewed articles and 18 book chapters and has presented original research at national and international conferences. He has spent his career managing hospital-acquired infections and antimicrobial resistance. His particular areas of interest relate to resistant gram negative pathogens and the treatment and prevention of infections caused by these organisms.
